drugset / Trial / NCT00453180

A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders

NCT00453180

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether treatment with oral N-acetylcysteine (NAC) will improve behavior problems often associated with autism spectrum disorders.

Timeline

Start
2007-03
Primary completion
2009-08
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 60 mg/kg Oral

Indications